Aspire Biopharma Holdings, Inc. Common Stock

ASBPNASDAQ • USD
ThemeNanotech & Adv. Materials›Nanomedicine & Drug Delivery
5.77 USD
↘ 0.29 (4.71%)🟢LIVE (AS OF 10:49 AM EDT)
🟢Market: OPEN
Open?$5.95
High?$5.95
Low?$5.71
Prev. Close?$6.05
Volume?52.5K
Avg. Volume?16.5M
VWAP?$5.83
Rel. Volume?0.00x
Bid / Ask
Bid?$4.88 × 100
Ask?$6.75 × 100
Spread?$1.87
Midpoint?$5.81
Valuation & Ratios
Market Cap?7.8M
Shares Out?1.3M
Float?4.5M
Float %?89.7%
P/E Ratio?N/A
P/B Ratio?2.03
EPS?-$9.08
Dividend?0.00%
Ex-Dividend?N/A

Aspire Biopharma Holdings, Inc. Common Stock (ASBP) is currently trading at $5.77. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. ASBP is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
Themes
Nanotechnology & Advanced Materials›Nanomedicine & Drug DeliveryBiotech - Drug Development›Clinical-Stage Platforms
Employees
N/A
Market Cap
7.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.aspirebiolabs.com
Listed
2025-02-20
Address
23150 FASHION DRIVE, SUITE 232
ESTERO, FL 33928
Phone: 561-704-8527
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
69
Short Sent.?
100
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.45Distress
Confidence?36%Very Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.69%Low
Short Interest?76.0K
Days to Cover?1.0
Free Float4.5M
Avg Daily Volume703.4K
Settlement Date2026-05-15
Financial Health
Current Ratio?2.26Strong
Quick Ratio?2.14Strong
Cash Ratio?1.86Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
73
2.03CHEAP▾
P/S?
Peers
100
S&P
3
226.77HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.4CHEAP▾
EV/Sales?
Peers
100
S&P
3
57.28HIGH▾
Returns & Efficiency
ROE?
S&P
3
-304.1%WEAK▾
ROA?
S&P
3
-165.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$2.0M
Fundamentals ratios updated end of day
MarketsMoversWatchlist